Therese E. O'Toole
Clinical Assistant Professor
Department of Clinical Sciences
Division of Critical Care
Phone: 508-839-5395
Fax: 508-839-7922
Email: theresa.otoole@tufts.edu

Education
DVM - Tufts University School of Veterinary Medicine - 1995

Board Certification
Internal Medicine (ACVIM) and Emergency and Critical Care (ACVECC)

General Research Interest

• Hematology
• Trauma and Shock
• Immune Mediated Hemolytic Anemia
• Coagulopathy

Research Sponsor Interest

• Privately Funded Research
• Federally Funded Research
• Internationally Funded Research

Selected Research Projects

• Prognostic Risk Factors for Dogs with Immune Mediated Hemolytic Anemia
• Coagulation Changes in Dogs with Severe Trauma
• Traumatic Brain Injury
• Outcome in Dogs with Portal Vein Thrombosis
• Outcome for Animals with Myasthenia Gravis Undergoing Removal of Thymoma
• Outcome in Dogs with Aortic Thromboembolism

Research and Clinical Interests

• Immune Mediated Hemolytic Anemia
• Severe Trauma
• Traumatic Brain Injury
• Shock
• Thrombosis

Selected Publications

1. Fenty RK, deLaforcade AM, Shaw SP, O’Toole TE. Identification of hypercoagulability in dogs with primary immune-mediated hemolytic anemia by means of thromboelastography. J Am Vet Med Assoc 2011;238:463-467.
2. Whelan MF, O’Toole TE, Chan DL, et al. Use of human mmunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated hemolytic anemia. J Vet Emerg Crit Car 2009;19:158–164.
3. Rogers CL, O'Toole TE, Keating DG, and Webster CRL. Portal Vein Thrombosis in Cats: 6 Cases (2001-2006) J Vet Int Med 2008;22:2; 282-287.
4. Abelson AL, Shelton DG, Whelan MF, Shaw S,F and O'Toole TE. Use of mycophenolate mofetil as a rescue agent in treatment of generalized myasthenia gravis in three dogs, J Vet Emerg and Crit Care, 2009;19:4;369-374.